Perioperative supplementation of EPA reduces immunosuppression induced by postoperative chemoradiation therapy in patients with esophageal cancer.
Takagi
K
K
Yamamori
H
H
Furukawa
K
K
Miyazaki
M
M
Tashiro
T
T
D004537:Eicosanoic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000276:immunology* / Q000532:radiotherapy / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects* / Q000528:radiation effects; D007111:Immunity, Cellular / Q000187:drug effects; D019990:Perioperative Care; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D012189:Retrospective Studies
D004537:Eicosanoic Acids